Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Orphanet Journal of Rare Diseases
|
August 26, 2015
Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD): exome sequencing of trios, monozygotic twins and tumours
Sarah F Barclay, Casey M Rand, Lauren A Borch, et al.
Kidney International
|
June 16, 2026
The role of platelet-derived growth factor in uremic vascular calcification
Burcu Yesilyurt Öztürk, Li Zhang, Saskia von Stillfried, et al.
Aging Cell
|
September 7, 2025
The Human Cardiac "Age-OME": Age-Specific Changes in Myocardial Molecular Expression
Cassandra Malecki, Giovanni Guglielmi, Benjamin Hunter, et al.
Lancet (London, England)
|
December 18, 2007
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Tammy F Chu, Maria A Rupnick, Risto Kerkela, et al.
Circulation Research
|
December 4, 2025
Human Hearts Intrinsically Increase Cardiomyocyte Mitosis After Myocardial Infarction
Robert D Hume, Jessica Warwick, Woo Jun Shim, et al.
Journal of Medicinal Chemistry
|
June 10, 2021
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer
Kevin D Freeman-Cook, Robert L Hoffman, Douglas C Behenna, et al.
Journal of Medicinal Chemistry
|
August 12, 2016
Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors
Pei-Pei Kung, Eugene Rui, Simon Bergqvist, et al.
Journal of Medicinal Chemistry
|
December 13, 2016
Correction to Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors
Pei-Pei Kung, Eugene Rui, Simon Bergqvist, et al.
Journal of Medicinal Chemistry
|
December 7, 2017
Optimization of Orally Bioavailable Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Using Ligand and Property-Based Design Strategies: Identification of Development Candidate (R)-5,8-Dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2H)-one (PF-06821497)
Pei-Pei Kung, Patrick Bingham, Alexei Brooun, et al.
Cancer Cell
|
September 14, 2021
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor
Kevin Freeman-Cook, Robert L Hoffman, Nichol Miller, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Orphanet Journal of Rare Diseases
|
August 26, 2015
Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD): exome sequencing of trios, monozygotic twins and tumours
Sarah F Barclay, Casey M Rand, Lauren A Borch, et al.
Kidney International
|
June 16, 2026
The role of platelet-derived growth factor in uremic vascular calcification
Burcu Yesilyurt Öztürk, Li Zhang, Saskia von Stillfried, et al.
Aging Cell
|
September 7, 2025
The Human Cardiac "Age-OME": Age-Specific Changes in Myocardial Molecular Expression
Cassandra Malecki, Giovanni Guglielmi, Benjamin Hunter, et al.
Lancet (London, England)
|
December 18, 2007
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Tammy F Chu, Maria A Rupnick, Risto Kerkela, et al.
Circulation Research
|
December 4, 2025
Human Hearts Intrinsically Increase Cardiomyocyte Mitosis After Myocardial Infarction
Robert D Hume, Jessica Warwick, Woo Jun Shim, et al.
Journal of Medicinal Chemistry
|
June 10, 2021
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer
Kevin D Freeman-Cook, Robert L Hoffman, Douglas C Behenna, et al.
Journal of Medicinal Chemistry
|
August 12, 2016
Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors
Pei-Pei Kung, Eugene Rui, Simon Bergqvist, et al.
Journal of Medicinal Chemistry
|
December 13, 2016
Correction to Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors
Pei-Pei Kung, Eugene Rui, Simon Bergqvist, et al.
Journal of Medicinal Chemistry
|
December 7, 2017
Optimization of Orally Bioavailable Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Using Ligand and Property-Based Design Strategies: Identification of Development Candidate (R)-5,8-Dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2H)-one (PF-06821497)
Pei-Pei Kung, Patrick Bingham, Alexei Brooun, et al.
Cancer Cell
|
September 14, 2021
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor
Kevin Freeman-Cook, Robert L Hoffman, Nichol Miller, et al.
Page
of 8